Krebs Biochemicals Industries Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Krebs Biochemicals & Industries Ltd is ₹ 57.85 as of 15 May 15:30 . The p/e ratio of Krebs Biochemicals & Industries Ltd changed from 0 to 0 over 9 quarters. This represents a CAGR of 0.0% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The market cap of Krebs Biochemicals & Industries Ltd changed from ₹ 144 crore to ₹ 131.56 crore over 5 quarters. This represents a CAGR of -6.97% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The revenue of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 7.28 crore as compare to the Sep '25 revenue of ₹ 4.17 crore. This represent the growth of 74.58% The revenue of Procter & Gamble Health Ltd for the Dec '25 is ₹ 378.22 crore as compare to the Sep '25 revenue of ₹ 329.87 crore. This represent the growth of 14.66% The ebitda of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0.3 crore as compare to the Sep '25 ebitda of ₹ -2.79 crore. This represent the decline of -110% The ebitda of Procter & Gamble Health Ltd for the Dec '25 is ₹ 114.82 crore as compare to the Sep '25 ebitda of ₹ 125.22 crore. This represent the decline of -8.31% The net profit of Krebs Biochemicals & Industries Ltd changed from ₹ -7.74 crore to ₹ -3.13 crore over 7 quarters. This represents a CAGR of -40.39% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 77.59 crore over 7 quarters. This represents a CAGR of 33.89% The dividend payout of Krebs Biochemicals & Industries Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Limited was initially incorporated as 'Krebs Biochemicals Limited' in 1991.
The name of the Company was changed from Krebs Biochemicals Limited to Krebs Biochemicals & Industries Limited effected from November 21, 2003.
Promoted by R T Ravi, Company engages in manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. The Company develops commercially viable biotech processes for application in medicine, agriculture and industry.
Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Krebs Biochemicals & Industries Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Krebs Biochemicals & Industries Ltd or Procter & Gamble Health Ltd?

Market cap of Krebs Biochemicals & Industries Ltd is 120 Cr while Market cap of Procter & Gamble Health Ltd is 8,734 Cr

What are the key factors driving the stock performance of Krebs Biochemicals & Industries Ltd and Procter & Gamble Health Ltd?

The stock performance of Krebs Biochemicals & Industries Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Krebs Biochemicals & Industries Ltd and Procter & Gamble Health Ltd?

As of May 18, 2026, the Krebs Biochemicals & Industries Ltd stock price is INR ₹55.71. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5261.9.

How do dividend payouts of Krebs Biochemicals & Industries Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Krebs Biochemicals & Industries Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.